These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25704864)

  • 1. Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study.
    Rochira V; Diazzi C; Santi D; Brigante G; Ansaloni A; Decaroli MC; De Vincentis S; Stentarelli C; Zona S; Guaraldi G
    Andrology; 2015 Mar; 3(2):298-308. PubMed ID: 25704864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV.
    De Vincentis S; Decaroli MC; Fanelli F; Diazzi C; Mezzullo M; Morini F; Bertani D; Milic J; Carli F; Cuomo G; Santi D; Tartaro G; Tagliavini S; De Santis MC; Roli L; Trenti T; Pagotto U; Guaraldi G; Rochira V
    Eur J Endocrinol; 2021 Jan; 184(1):107-122. PubMed ID: 33112262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men.
    Grinspoon S; Corcoran C; Stanley T; Baaj A; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 2000 Jan; 85(1):60-5. PubMed ID: 10634364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
    Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy.
    Rietschel P; Corcoran C; Stanley T; Basgoz N; Klibanski A; Grinspoon S
    Clin Infect Dis; 2000 Nov; 31(5):1240-4. PubMed ID: 11073758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypogonadism in the HIV-infected man.
    Rochira V; Guaraldi G
    Endocrinol Metab Clin North Am; 2014 Sep; 43(3):709-30. PubMed ID: 25169563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
    Wasserman P; Segal-Maurer S; Rubin D
    J Sex Med; 2008 Jan; 5(1):241-7. PubMed ID: 17961146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature decline of serum total testosterone in HIV-infected men in the HAART-era.
    Rochira V; Zirilli L; Orlando G; Santi D; Brigante G; Diazzi C; Carli F; Carani C; Guaraldi G
    PLoS One; 2011; 6(12):e28512. PubMed ID: 22174826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.
    Arver S; Sinha-Hikim I; Beall G; Guerrero M; Shen R; Bhasin S
    J Androl; 1999; 20(5):611-8. PubMed ID: 10520573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has prolactin a role in the hypogonadal status of HIV-infected patients?
    Collazos J; Esteban M
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):43-6. PubMed ID: 19171915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).
    Teichmann J; Lange U; Discher T; Lohmeyer J; Stracke H; Bretzel RG
    Eur J Med Res; 2009; 14(2):59-64. PubMed ID: 19258214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism.
    Katznelson L; Finkelstein JS; Schoenfeld DA; Rosenthal DI; Anderson EJ; Klibanski A
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4358-65. PubMed ID: 8954042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project.
    Travison TG; Nguyen AH; Naganathan V; Stanaway FF; Blyth FM; Cumming RG; Le Couteur DG; Sambrook PN; Handelsman DJ
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2464-74. PubMed ID: 21677041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.